Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lupus Erythematosus, Systemic × gusacitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Basal Cell Nevus Syndrome 2 Skin Neoplasms 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Carcinoma, Basal Cell 1

Interventions

Nivolumab 2 sotrovimab 1 gusacitinib 1 ciclesonide 1 Specimen Handling 1 Niclosamide 1 High-Intensity Interval Training 1 Exercise 1 Cholecalciferol 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06238531 2025-03-13

A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn

Lupus Erythematosus, Systemic, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡